BIOMAT Database Logo BIOMAT Database Logo

Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus. 1998

N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Department of Nuclear Medicine and Diagnostic Imaging, Kyoto University, Japan.

The purpose of this study was to evaluate oxidative metabolism and its response by dobutamine in patients with noninsulin-dependent diabetes mellitus (NIDDM) using 11C-acetate PET. METHODS We studied 16 patients with NIDDM (9 men, 7 women; mean age 53.7 +/- 12.8 yr) and 6 healthy male control subjects (mean age 41.8 +/- 17.2 yr). None of them had an abnormality on stress-perfusion SPECT. The 11C-acetate clearances (Kmono) were compared regionally for five myocardial segments in all subjects at rest and during low-dose dobutamine stress in 13 patients (8 patients with NIDDM, age 51.9 +/- 13.6 yr; 5 healthy male control subjects, age 45.6 +/- 16.3 yr). Correlation between regional Kmono and rate-pressure product (RPP) was also studied. RESULTS At rest, the clearance of 11C-acetate was slightly heterogeneous for both patients with NIDDM and healthy control subjects, with smaller values in the apex and inferior wall in both groups. The difference became significant during dobutamine stress in the patients. The RPP-to-Kmono (average for five segments) ratio at rest was slightly smaller in the patients (1042.7 +/- 559.1 x 0.01) than in the healthy control subjects (1391.4 +/- 209.6 x 0.01, not significant), and those during dobutamine stress were almost the same in the two groups (1457.3 +/- 737.4 x 0.01 and 1486.0 +/- 211.8 x 0.01, respectively). A significant correlation was seen between regional Kmono and RPP in every segment in the healthy control subjects (average; r = 0.89; p < 0.01), whereas more scattered correlation with greater regional variation was observed in the patients (average; r = 0.31; p value was not significant). CONCLUSIONS Patients with NIDDM showed slight regional heterogeneity in myocardial oxidative metabolism. They also had more scattered correlation between myocardial oxidative metabolism and cardiac work (RPP) than healthy control subjects, with the smallest correlation coefficient observed in the inferior wall. These findings may help the understanding of dynamics in myocardial oxidative metabolism of NIDDM hearts.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004280 Dobutamine A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. Dobucor,Dobuject,Dobutamin Fresenius,Dobutamin Hexal,Dobutamin Solvay,Dobutamin-ratiopharm,Dobutamina Inibsa,Dobutamina Rovi,Dobutamine (+)-Isomer,Dobutamine Hydrobromide,Dobutamine Hydrochloride,Dobutamine Lactobionate,Dobutamine Phosphate (1:1) Salt, (-)-Isomer,Dobutamine Tartrate,Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer,Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer,Dobutamine, (-)-Isomer,Dobutamine, Phosphate (1:1) Salt (+)-Isomer,Dobutrex,Lilly 81929,Oxiken,Posiject,Dobutamin ratiopharm,Hydrobromide, Dobutamine,Hydrochloride, Dobutamine,Lactobionate, Dobutamine,Tartrate, Dobutamine
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts

Related Publications

N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
March 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Noninsulin-dependent diabetes mellitus.
July 1991, American family physician,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Noninsulin dependent diabetes mellitus.
February 1993, The New Zealand medical journal,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Noninsulin dependent diabetes mellitus.
March 1993, The New Zealand medical journal,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Hypertriglyceridemia in noninsulin dependent diabetes mellitus.
April 1988, Seminars in thrombosis and hemostasis,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Metformin in noninsulin-dependent diabetes mellitus.
January 1996, Pharmacotherapy,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Management of noninsulin-dependent diabetes mellitus.
February 1980, American family physician,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Management of noninsulin-dependent diabetes mellitus.
November 1988, The Medical clinics of North America,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
December 1990, The Journal of clinical endocrinology and metabolism,
N Hattori, and N Tamaki, and T Kudoh, and I Masuda, and Y Magata, and H Kitano, and M Inubushi, and E Tadamura, and K Nakao, and J Konishi
Screening for noninsulin dependent diabetes mellitus.
July 1992, The New Zealand medical journal,
Copied contents to your clipboard!